There is a new round of vaccines that work on BA5, the dominant variant as of August in the US.

(yes; this is recent news; everything I'm describing above is about the previous round of viruses. The new vaccines are in only limited availabiltiy right now)

Oh. My bad. I thought you said "There's no value proposition to vaccination at this point."

Even boosters are a bit of a question in my mind. I had forgotten they were already approved recently. There really ahsn't been much discussion at UCSF about it other than "it's available we're still evaluating data before making recommendations".

What I should have said was "nobody should take the pre-bivalent boosters with any expectation of seeing a reduction in infection chances, or severity of disease, based on our current understanding of omicron, while bivalent boosters seem promising, even though we have extremely limited data and won't know for sure until after the winter cycle."

Like the Omicron booster that has limited availability?

I believe those were approved a couple months ago and become available very recently. I was expecting Denmark to resume once that was available (they actually shut down the vaccine problem back in the spring with the plan to restart in the fall with the new booster).